Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gerloff

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 5, 2003
Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distributionThomas Gerloff
Pharmacogenetics and Genomics|November 17, 2006
In-vitro transport characteristics discriminate wild-type ABCB1 (MDR1) from ALA893SER and ALA893THR polymorphismsMelanie Schaefer, Ivar Roots, Thomas Gerloff
European Journal of Clinical Pharmacology|January 11, 2008
Comparison of SLCO1B1 sequence variability among German, Turkish, and African populationsJessica Mwinyi, Karla Köpke, Melanie Schaefer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 1, 2005
Quantification of pravastatin in human plasma and urine after solid phase extraction using high performance liquid chromatography with ultraviolet detectionSteffen Bauer, Jessica Mwinyi, Angela Stoeckle, et al.
Clinical Pharmacology and Therapeutics|April 30, 2004
Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kineticsJessica Mwinyi, Andreas Johne, Steffen Bauer, et al.
Fundamental & Clinical Pharmacology|August 14, 2003
MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytesKersti Oselin, Thomas Gerloff, Przemyslaw M Mrozikiewicz, et al.
European Journal of Biochemistry|July 24, 2002
Functional analysis of the rat bile salt export pump gene promoterThomas Gerloff, Andreas Geier, Ivar Roots, et al.
British Journal of Clinical Pharmacology|December 21, 2002
MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white malesThomas Gerloff, Melanie Schaefer, Andreas Johne, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 12, 2003
Implications of pharmacogenetics for individualizing drug treatment and for study designChristian Meisel, Thomas Gerloff, Julia Kirchheiner, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 29, 2006
Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levelsThomas Gerloff, Melanie Schaefer, Jessica Mwinyi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 5, 2003
Impact of genetic polymorphisms in transmembrane carrier-systems on drug and xenobiotic distributionThomas Gerloff
Pharmacogenetics and Genomics|November 17, 2006
In-vitro transport characteristics discriminate wild-type ABCB1 (MDR1) from ALA893SER and ALA893THR polymorphismsMelanie Schaefer, Ivar Roots, Thomas Gerloff
European Journal of Clinical Pharmacology|January 11, 2008
Comparison of SLCO1B1 sequence variability among German, Turkish, and African populationsJessica Mwinyi, Karla Köpke, Melanie Schaefer, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 1, 2005
Quantification of pravastatin in human plasma and urine after solid phase extraction using high performance liquid chromatography with ultraviolet detectionSteffen Bauer, Jessica Mwinyi, Angela Stoeckle, et al.
Clinical Pharmacology and Therapeutics|April 30, 2004
Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kineticsJessica Mwinyi, Andreas Johne, Steffen Bauer, et al.
Fundamental & Clinical Pharmacology|August 14, 2003
MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytesKersti Oselin, Thomas Gerloff, Przemyslaw M Mrozikiewicz, et al.
European Journal of Biochemistry|July 24, 2002
Functional analysis of the rat bile salt export pump gene promoterThomas Gerloff, Andreas Geier, Ivar Roots, et al.
British Journal of Clinical Pharmacology|December 21, 2002
MDR1 genotypes do not influence the absorption of a single oral dose of 1 mg digoxin in healthy white malesThomas Gerloff, Melanie Schaefer, Andreas Johne, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 12, 2003
Implications of pharmacogenetics for individualizing drug treatment and for study designChristian Meisel, Thomas Gerloff, Julia Kirchheiner, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 29, 2006
Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levelsThomas Gerloff, Melanie Schaefer, Jessica Mwinyi, et al.
Pageof 2